|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
09-15-2010, 08:26 PM
|
|||
|
|||
Bone marrow-derived mononuclear cell therapy benefits patients after severe heart att
The first randomized, placebo-controlled U.S. clinical trial to assess the use of bone marrow-derived mononuclear cells (BMC) in patients after a ST-elevation myocardial infarction (STEMI; severe heart attack) demonstrated a strong safety profile for this cell therapy, based on phase 1 results published in the September issue of the American Heart Journal.
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Bone marrow donor has change of heart | cancerfr | Bone Cancer | 0 | 10-04-2010 02:00 AM |
| Bone Marrow Transplant Success Rate May Be Improved By Inhibiting Cell Signaling Path | cancerfr | Bone Cancer | 0 | 09-28-2010 06:01 PM |
| Inhibiting Cell Signaling Pathway May Improve Bone Marrow Transplant Success Rate | cancerfr | Bone Cancer | 0 | 09-28-2010 06:01 PM |
| Inhibiting cell signaling pathway may improve bone marrow transplant success rate | cancerfr | Bone Cancer | 0 | 09-27-2010 08:47 PM |
| Commonly used type of bone marrow stem cell may help treat sepsis, new study suggests | cancerfr | Bone Cancer | 0 | 07-01-2010 07:45 PM |
Linear Mode
